Correlation Between AptaBio Therapeutics and Kuk Young
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Kuk Young at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Kuk Young into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Kuk Young GM, you can compare the effects of market volatilities on AptaBio Therapeutics and Kuk Young and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Kuk Young. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Kuk Young.
Diversification Opportunities for AptaBio Therapeutics and Kuk Young
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AptaBio and Kuk is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Kuk Young GM in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kuk Young GM and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Kuk Young. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kuk Young GM has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Kuk Young go up and down completely randomly.
Pair Corralation between AptaBio Therapeutics and Kuk Young
Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Kuk Young. But the stock apears to be less risky and, when comparing its historical volatility, AptaBio Therapeutics is 3.17 times less risky than Kuk Young. The stock trades about -0.29 of its potential returns per unit of risk. The Kuk Young GM is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 204,500 in Kuk Young GM on September 3, 2024 and sell it today you would lose (9,800) from holding Kuk Young GM or give up 4.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AptaBio Therapeutics vs. Kuk Young GM
Performance |
Timeline |
AptaBio Therapeutics |
Kuk Young GM |
AptaBio Therapeutics and Kuk Young Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AptaBio Therapeutics and Kuk Young
The main advantage of trading using opposite AptaBio Therapeutics and Kuk Young positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Kuk Young can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kuk Young will offset losses from the drop in Kuk Young's long position.AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Kuk Young vs. DB Financial Investment | Kuk Young vs. Shinhan Financial Group | Kuk Young vs. Wonil Special Steel | Kuk Young vs. DONGKUK STEEL MILL |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |